01 CARBIDOPA; LEVODOPA (3)
01 UCB INC (3)
01 TABLET, ORALLY DISINTEGRATING;ORAL (3)
01 10MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (3)
19
UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARBIDOPA; LEVODOPA, with a corresponding application number 76699 and regulatory information .
proudly manufactured in the
approval since 2004-08-27
UCB Pharma S.A's PARCOPA TABLET, ORALLY DISINTEGRATING;ORAL, medication with 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of CARBIDOPA; LEVODOPA.
18
UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARBIDOPA; LEVODOPA, with a corresponding application number 76699 and regulatory information .
proudly manufactured in the
approval since 2004-08-27
UCB Pharma S.A's PARCOPA TABLET, ORALLY DISINTEGRATING;ORAL, medication with 25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of CARBIDOPA; LEVODOPA.
17
UCB Pharma S.A, based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARBIDOPA; LEVODOPA, with a corresponding application number 76699 and regulatory information .
proudly manufactured in the
approval since 2004-08-27
UCB Pharma S.A's PARCOPA TABLET, ORALLY DISINTEGRATING;ORAL, medication with 10MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of CARBIDOPA; LEVODOPA.